Columbus Macro’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Columbus Macro's BMY Position: Q3 2026 in Review
Columbus Macro increased its Bristol-Myers Squibb (BMY) stake by 0.32% in Q3 2026, buying an estimated $8.6K and bringing the position to 42,170 shares worth $2.63M. The position accounts for 0.26% of the portfolio, ranked #115.
Columbus Macro first reported a position in BMY in Q4 2019 and has held it in 16 quarters since. 471 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- Columbus Macro held 42,170 shares of Bristol-Myers Squibb worth $2.63M as of Q3 2026.
- Columbus Macro bought 136 Bristol-Myers Squibb shares in Q3 2026, an estimated $8.6K.
- Bristol-Myers Squibb made up 0.26% of Columbus Macro's portfolio in Q3 2026, its #115 holding.
- Columbus Macro first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 16 quarters since.
- 471 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on Columbus Macro's 13F filing for Q3 2026, filed 14 Oct 2026.